baber/WOPTO huggingface dataset:
Patent DK-1583571-T3 (DK)
Inventor: LYNGSIE MICHAEL GORM
IPC: A61M5/31
Filed: 2003-12-19
Granted: 2008-06-16
Abstract: A disposable, wearable, self-contained insulin dispensing device includes a housing and an insulin source in the housing that is connected to a catheter for injecting insulin into a user.
Patent DK-1647556-T3 (DK)
Inventor: HENTSCH BERND
IPC: A61K38/04
Filed: 2004-10-14
Granted: 2010-07-19
Abstract: The present invention provides peptide derivatives designed to deliver growth factor receptor inhibitory activity. The invention relates to the use of such peptide drugs and derivatives thereof for the treatment of human diseases through the inhibition of growth factor receptor signaling, in particular involving signals mediated by hepatocyte growth factor (HGF), c-met and CD44. The invention comprises a use of compounds for the treatment and prevention of hyperproliferative disorders or diseases associated with an increased invasive potential of cells, such as cancer, including the treatment and prevention of tumor metastases and minimal residual disease. The invention includes the manufacture of a clinically used medicament for the treatment and prevention of human diseases associated with abberant gene expression patterns due to aberrant signaling via HGF.
Patent DK-1522545-T3 (DK)
Inventor: DE KLEIJN PAUL
IPC: C08F220/06
Filed: 2004-10-05
Granted: 2011-09-26
Abstract: The present invention relates to a method for manufacturing super-absorbent polymers, comprising of providing a reaction mixture which comprises at least a first monomer and a second monomer and a radical-forming polymerization initiator, and subsequently causing the monomers to polymerize under the influence of an energy source, wherein radical formation occurs and the polymerization is started, wherein the first monomer is neutralized with an inorganic base before polymerization, in addition to the manufactured super-absorbent polymers. The invention further relates to a method for applying a coating of super-absorbent polymers to a carrier, comprising of impregnating the carrier with a reaction mixture comprising at least a first monomer neutralized with an inorganic base and a second monomer and a radical-forming polymerization initiator, and causing the monomers to polymerize on the carrier under the influence of an energy source wherein radical formation occurs and the polymerization is started, and to the formed carrier and the use thereof.
Patent DK-1581588-T3 (DK)
Inventor: METZEMACHER HEINZ-DIETER
IPC: C09C1/42
Filed: 2004-01-08
Granted: 2007-04-02
Abstract: The invention relates to a composition, in particular a pulverulent master batch, comprising at least one nanoclay composed of a swellable inorganic layered material which has been modified by at least one siloxane component and by at least one non-anionic organic compound which has at least one aliphatic or cyclic radical having from 6 to 32 carbon atoms. The pulverulent master batch can result in a homogeneous mixture with a polymer powder and can be used as such. Also, a polymer master batch can be produced by compounding of the pulverulent master batch with a carrier polymer. The pulverulent master batch or the polymer master batch can be used as filler or in filler systems in various polymer compositions.
Patent DK-1654188-T3 (DK)
Inventor: LAUVDAL OLAV
IPC: B66F9/18
Filed: 2004-06-29
Granted: 2008-09-01
Abstract: A device for mounting on an implement carrier such as a fork lift truck, hoisting crane or the like in order to move, hold or lift an object. The device comprises—a carrier part which is mounted on the implement carrier preferably by the carrier part being in the form of a sleeve which is inserted on the implement carrier's fork structure, and—a holding part which is attached to the carrier. part, the holding part being provided with at least one securing device with characteristics that make it possible to secure an object by contact between at least one of the object's surfaces and the securing device, —a trigger that ensures that the forces acting between the object's surface and the securing device are broken or discontinued, thus releasing the object.
Patent DK-1648814-T3 (DK)
Inventor: SLETTAOEYEN ODD
IPC: A47C27/14
Filed: 2004-07-15
Granted: 2007-07-02
Abstract: The present invention relates to process for the manufacturing of mattresses characterized in that a liquid molding substance of the same material as the construction pieces (1, 3, 4, 6) is used in all the joints between the pieces. The process comprises steps wherein: the bottom piece (1) is laid out; the molding substance (2) is applied to the longitudinal edges (3) and cross edges (4) on one surface side of the bottom piece (1); the longitudinal pieces (3) and cross pieces (4) are lowered into a molding substance (2) and hardened; the molding substance (2) is applied on the same surface side of the bottom piece (1) between the longitudinal pieces (3) and cross pieces (4); a core (6) is lowered into the molding substance (2) and hardened; and the top piece (7) is provided with molding substance (2) and turned with the molding substance (2) facing the named upright longitudinal pieces (3) and cross pieces (4) and lowered onto the same and hardened.
Patent DK-1696790-T3 (DK)
Inventor: POLIDORI DAVID
IPC: G06F19/00
Filed: 2004-11-19
Granted: 2012-01-23
Abstract: Apparatus and methods for assessing metabolic substrate utilization are described. In one embodiment, a processor-readable medium includes code to receive data indicative of a plasma glucose concentration, a plasma free fatty acid concentration, and a respiratory quotient of a subject. The processor-readable medium also includes code to calculate, based on the data, respective values of a set of metabolic parameters. The set of metabolic parameters includes a first metabolic parameter and a second metabolic parameter. The value of the first metabolic parameter is indicative of whether the subject has a predisposition towards oxidation of a first type of metabolic substrate or a second type of metabolic substrate, and the value of the second metabolic parameter is indicative of the subject's responsiveness to a change in availability of the first type of metabolic substrate or the second type of metabolic substrate.
Patent DK-1668986-T3 (DK)
Inventor: DR LAY NORBERT
IPC: A22B5/00
Filed: 2005-09-20
Granted: 2007-08-27
Abstract: In a process to eviscerate an animal cadaver, the rectum is separated from the carcass by a powered cutting assembly. The assembly has a suction passage (5) within a hollow cylindrical circular cutting blade (3) also enclosing a guide pin (4). The blade and guide pin are powered by compressed air. The unit consists essentially of the tool (2) and a separable robotic connection plate (1). The robotic connection plate has a vacuum connector aperture (11), water feed connector fitting (12), a connector fitting (13) for compressed air feed to the motor (25), and a compressed air outlet (14). Following assembly the tool (2) connectors (11-14) are co-located with the commensurate ducts in the robotic connection plate (1). Also claimed is a commensurate cylindrical cutting tool.
Patent DK-1848096-T3 (DK)
Inventor: CLARK PAUL EATON
IPC: H02K21/12
Filed: 2007-04-16
Granted: 2011-09-26
Abstract: The present invention provides an electrical machine (1) with reduced cogging. The magnet poles (3) of the electrical machine are comprised of at least two separate groups of at least two circumferentially adjacent magnet poles. One of the circumferentially outer magnet poles (3a, 3h) in one of the groups of magnet poles is defined as being in its reference position. The reference position of each other magnet pole (3b to 3g) is defined as the position each other magnet pole would occupy if all the magnet poles were equally circumferentially spaced around the first or second body and the one circumferentially outer pole was in its reference position. At least one of the circumferentially outer magnet poles (3a, 3h) in each group is sited in its reference position. At least one magnet pole (3a to 3g) in each group is a displaced magnet pole and is sited in a position that is displaced from its reference position by an amount that is not equal to an integral multiple of the reference angular pitch of the winding slots. The displacement of the magnet poles (3) provides a pronounced reduction in cogging.
Patent DK-2083893-T3 (DK)
Inventor: LEIDIG JUERGEN
IPC: A61M5/32
Filed: 2007-09-06
Granted: 2010-04-06
Abstract: The invention relates to a device for mounting a needle guard onto a syringe body that is provided with a needle. The device includes a retaining device for retaining the syringe body, a needle guard receptacle for receiving the needle guard, a compressed air system for providing compressed air, a first displacement device for displacing the needle guard receptacle in a vertical direction, and a rotation device for at least partially rotating the needle guard receptacle. The needle guard receptacle is disposed beneath the retaining device while the compressed air is fed to the needle guard receptacle such that the needle guard is suspended on an air cushion in a floating manner. The needle guard receptacle can be displaced in a vertical direction by the first displacement device. The invention further relates to a method for mounting the needle guard onto the syringe body.
Patent DK-1981339-T3 (DK)
Inventor: LOCKETT JOHN
IPC: A01N33/18
Filed: 2007-12-20
Granted: 2012-06-25
Abstract: The invention relates to the use of, or method of using, a composition comprising ethofumesate in the protection of wheat crops. The crop is preferably winter wheat and is preferably pre-emergences or crop emergence not before ZCK 13. Compositions comprising ethofumesate in combination with other herbicides are also provided.
Patent DK-2271638-T3 (DK)
Inventor: SONESSON CLAS
IPC: A61P25/00
Filed: 2009-04-28
Granted: 2011-11-28
Abstract: The present invention relates to novel 1-(4H-1,3-benzodioxin-2-yl)methanamine derivatives, useful as modulators of dopamine neurotransmission, and more specifically asdopaminergic stabilizers. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
Patent DK-2369224-T3 (DK)
Inventor: ALLEGRI FABIO
IPC: F21S8/00
Filed: 2010-12-27
Granted: 2012-08-20
Abstract: A LED light projector, comprising: 
a plurality of LED light sources (3) capable of emitting a corresponding number of light beams (4); 
a box-like body (7) internally housing the light sources (3) and having interior walls (7a) which are painted white such as to mix the light beams (4) such that a single beam (14) is emitted; 
a frosted optical lens (8) placed opposite the light sources (3).
Patent DK-2579874-T3 (DK)
Inventor: NORTON RICHARD L
IPC: A61K47/34
Filed: 2011-06-06
Granted: 2018-01-29
Abstract: The present invention is directed to a buprenorphine sustained release delivery system capable of delivering buprenorphine, a metabolite, or a prodrug thereof for a duration of about 14 days to about 3 months. The buprenorphine sustained release delivery system includes a flowable composition and a solid implant for the sustained release of buprenorphine, a metabolite, or a prodrug thereof. The implant is produced from the flowable composition. The buprenorphine sustained release delivery system provides in situ 1-month and 3-month release profiles characterized by an exceptionally high bioavailability and minimal risk of permanent tissue damage and typically no risk of muscle necrosis.
Patent DK-2852418-T3 (DK)
Inventor: ALLEN JULIE
IPC: A61M1/00
Filed: 2013-05-22
Granted: 2018-07-16
Abstract: Disclosed herein are several embodiments of a negative pressure appliance and methods of using the same in the treatment of wounds. Some embodiments are directed towards wound dressings comprising a liquid and gas permeable transmission layer, an absorbent layer for absorbing wound exudate, the absorbent layer overlying the transmission layer, a gas impermeable cover layer overlying the absorbent layer and comprising a first orifice, wherein the cover layer is moisture vapor permeable. Some embodiments are directed to improved fluidic connectors or suction adapters for connecting to a wound site, for example using softer, kink-free conformable suction adapters.
Patent DK-2997980-T3 (DK)
Inventor: GEARY RICHARD S
IPC: C12N15/11
Filed: 2005-08-10
Granted: 2018-03-26
Abstract: Methods for the rapid and long-term lowering of lipid levels in human subjects and for the treatment of conditions associated with elevated LDL-cholesterol and elevated apolipoprotein B are provided.
Patent DK-0388989-T3 (DK)
Inventor: WANG JOHNNY
IPC: A43C1/00
Filed: 1990-03-23
Granted: 1994-12-12
Abstract: The shoe fastening is characterised in that it has an exchangeable combination of a shoelace fastening with a touch-and-close fastening.
Patent DK-0416761-T3 (DK)
Inventor: CONSTANTZ BRENT R
IPC: A61K6/838
Filed: 1990-08-13
Granted: 1993-04-19
Abstract: Calcium phosphate minerals are formed by using phosphoric acid source substantially free of uncombined water in conjunction with a calcium source, normally as any combination of carbonate, phosphate and hydroxide, and, as required, any additional base to neutralize the phosphoric acid. Protein may be optionally added. The resulting product is readily formed and then sets to a hard, stable, workable shaped object.
Patent DK-0425082-T3 (DK)
Inventor: CHARLES IAN GEORGE
IPC: A61P31/04
Filed: 1990-09-03
Granted: 1995-07-03
Abstract: A polypeptide suitable for use in a vaccine against Bordetella pertussis, B. parapertussis or B. bronchiseptica presents an epitope comprising:   (a) the amino acid sequence coded for by nucleotides 1885 to 1902 of the p.69 gene of B. pertussis CN2992; (b) the corresponding amino acid sequence of another strain of B. pertussis or of a strain of B. parapertussis or B. bronchiseptica; or   (c) a said sequence (a) or (b) which has been modified such that the modified sequence has substantially the same antigenicity as that of the said sequence (a) or (b); the said polypeptide being no more than 50 amino acid residues long or being a chimaeric protein having an amino acid sequence comprising the sequence of a carrier protein and a foreign sequence of no more than 50 amino acid residues which comprises the sequence of a said epitope. i
Patent DK-0472981-T3 (DK)
Inventor: FISCHER WILHELM
IPC: B31B120/70
Filed: 1991-08-09
Granted: 1995-11-06
Abstract: Method for erecting a foldable box from a one-part cardboard blank which has a bottom surface, side walls articulated on this via folding lines and a front wall and rear wall, there being formed on the side wall flaps which are folded into the region of the front and rear walls, and which is coated at least partially with a sealable plastic. At the same time, the two side walls are first erected in that the cardboard blank is pressed into a U-shaped bottom mould (4). The flaps are folded in by means of rotating drivers (30); the rear wall and front wall are heated until the plastic coating becomes sealable, whereupon the rear wall and front wall and the flaps are pressed against one another and sealed together. 
<IMAGE>
Patent DK-0463916-T3 (DK)
Inventor: GELIS ALAIN DE
IPC: A47C/
Filed: 1991-06-14
Granted: 1993-05-03
Abstract: A slatted bed base comprising a series of units (13) each of which includes an upper slat (3) on a lower support (5) mounted on a rigid, central and longitudinal beam (7) which is fixed in relation to the floor. The lower support (5) and the upper slat (3) are connected by a flexible linking element (14) allowing relative movement between the support (5) and the slat (3). The units (13) are spaced apart so that they can move independently of each other.
Patent DK-0466586-T3 (DK)
Inventor: DHAINAUT ALAIN
IPC: A61K31/53
Filed: 1991-07-10
Granted: 1995-04-03
Abstract: New polymethylene-imines which can be used as medicaments and which correspond to the formula: 
<IMAGE>
 in which:
 X, A, Z, R, R1, R2, R3, R4, Y, Y', m and n are as defined in the description. 
<??>These new derivatives and their physiologically tolerable salts may be used in therapy, in particular for abolishing the resistance of tumour cells to anticancer agents and for abolishing the resistance of parasites to antiparasitic agents.
Patent DK-0484198-T3 (DK)
Inventor: SARRADIN JEAN-LOUIS
IPC: G06Q20/00
Filed: 1991-10-21
Granted: 1999-09-27
Abstract: The terminals each comprise transaction data acquisition means (70, 72, 76, 77), a wireless communication interface (79) with a distant central station and having electronic initialisation and means (70, 76, 77, 79) arranged in order, in the course of a transaction, to communicate with the central station. These terminals are configured into a non-cabled network. These terminals permit certain professionals and tradespeople not to require their clients to move in order to acquire their confidential code. <IMAGE>
Patent DK-0512538-T3 (DK)
Inventor: BENKESER MICHAEL DIPL-ING FH
IPC: B01D17/02
Filed: 1992-05-07
Granted: 1996-01-15
Abstract: A liquid separator which serves, in particular, for separating mixtures of water and liquids of lower relative density such as oil, petroleum or the like, is equipped with a container (11), which has an inlet (12) and an outlet (15), and a separating region (16) connected to the inlet. In order to enable simple and reliable discharge and/or elimination of the separated liquid, a stationary conveying apparatus (30) is provided in the liquid separator, by means of which the liquid separated in the separating region can be transported into a collecting container (22). <IMAGE>
Patent DK-0575442-T3 (DK)
Inventor: HANSEN HOLGER CLAUS
IPC: A61P25/00
Filed: 1992-02-19
Granted: 1996-05-06
Abstract: Imidazotriazoloquinazoline compounds having the general formula <IMAGE>  wherein A together with the  alpha -marked carbon atom and the  beta -marked nitrogen atom is one of the groups  <IMAGE> <IMAGE>  <IMAGE>  cyano or CO2R5, wherein R5 is H, alkyl, cycloalkyl, trifluoromethyl or alkoxymethyl; and R2, R3 and R4 independently are H, hydroxy, halogen, CN, alkyl, alkenyl, alkynyl, trifluoromethyl, alkoxy, dialkylaminoalkoxy, aralkoxy, aryloxy which may be substituted, acyclic amino group, or NR6R7, wherein R6 and R7 independently are H or alkyl. The compounds are useful in psychopharmaceutical preparations as anticonvulsants, anxiolytics, hypnotics, antipsychotics, antiemetics, or in improving the cognitive function of the brain of mammals, or as benzodiazepine antagonsists.
Patent DK-0587791-T3 (DK)
Inventor: WURM FLORIAN M
IPC: C12N15/67
Filed: 1992-05-29
Granted: 2004-07-26
Abstract: PCT No. PCT/US92/04469 Sec. 371 Date Jan. 28, 1994 Sec. 102(e) Date Jan. 28, 1994 PCT Filed May 29, 1992 PCT Pub. No. WO92/21763 PCT Pub. Date Dec. 10, 1992Methods are provided for the identification and use of endogenous nucleic acid sequences for homologous recombination and targeted integration of heterologous nucleic acid sequences. These methods are useful for introduction of nucleic acid into cells or tissue for gene therapy, or for the preparation of transgenic animals. Methods are also provided for enhancing the yield of genes of interest from recombinant cell culture lines.
Patent DK-0585693-T3 (DK)
Inventor: SHALEV DORON
IPC: H04B7/15
Filed: 1993-08-13
Granted: 1999-04-06
Abstract: Fig. 1, illustrates a communications system (10) comprising a base station (12) for controlling a control channel signal and a plurality of traffic channels and a communications device (17) responsive to said control channel signal (16) and receptive to said plurality of traffic channels. The communications device comprises a tuneable filter (48), having an adjustable characteristic, which substantially filters all but a selected traffic channel of said plurality of traffic channels. The communications device further comprises a tuning circuit (24, 38 40, 44, 46, 52) for adjusting said filter characteristic. The tuning circuit (24, 38, 40, 44, 46, 52) uses the control channel signal (16) as an accurate central frequency (F0) for a passband of the tuneable filter (48) and adjusts said filter characteristic to substantially a minimum insertion loss at said accurate central frequency, thereby substantially optimising selectivity and sensitivity for the communications device (17). <IMAGE>
Patent DK-0555087-T3 (DK)
Inventor: BREBOROWICZ ANDRZEJ
IPC: A61K38/44
Filed: 1993-02-04
Granted: 1999-05-03
Abstract: A peritoneal dialysis solution comprises physiological salts in concentrations sufficient to affect the removal of solutes by diffusion from the patient's blood across the peritoneal membrane into the solution. The solution includes at least one compound selected from vitamin E, procysteine, and superoxide dismutase to scavenge free radicals generated by activated peritoneal macrophages during peritonitis. The invention also uses these compounds, or chondroitin sulphate in the manufacture of a dialysis solution, for preventing injury to mesothelial cells.
Patent DK-0689504-T3 (DK)
Inventor: CERASO BRUNO
IPC: B29L31/34
Filed: 1993-03-31
Granted: 1997-08-25
Abstract: PCT No. PCT/IT93/00029 Sec. 371 Date Aug. 4, 1995 Sec. 102(e) Date Aug. 4, 1995 PCT Filed Mar. 31, 1993 PCT Pub. No. WO94/21459 PCT Pub. Date Sep. 29, 1994Process for automatic connection, at the moment of pressing, between a source (26) of electric current and the metal parts (35), connected in series, of the piles (30) of packages (31) for making plastic laminates to permit electric endothermic heating, there being placed in the pressing machines (10), at those parts which will come in contact with the ends (36,37) of the pile (30), metal contact sheets (20,21) connected to the source (26) of electric current.
Patent DK-0614888-T3 (DK)
Inventor: MARTIN LAWRENCE LEO
IPC: A61K31/40
Filed: 1994-02-28
Granted: 1997-11-03
Abstract: There are disclosed various compounds of the formula below, <CHEM> where the various parameters R1, R2, R3, R4, X, m and n are as defined in the specification, which show activities as a monoamine oxidase inhibitor demonstrating a utility for the treatment of depression, and activities as a cholinesterase inhibitor demonstrating a utility for the treatment of various memory dysfunctions such as Alzheimer's disease.
Patent DK-0630922-T3 (DK)
Inventor: STEPHAN WERNER
IPC: C09D175/00
Filed: 1994-05-17
Granted: 1998-02-02
Abstract: The invention relates to coating compositions which are suitable for use as primers and fillers in the production of multicoat finishes, in particular in the automotive sector. The coating compositions contain a binder mixture comprising   A) 60 - 75% by weight of a hydroxy-functional copolymer having an OH number of from 110 to 170 mg KOH/g, obtainable from   a) 5 - 60% by weight, preferably 10 - 30 % by weight, of at least one diester of an alpha, beta-olefinically unsaturated dicarboxylic acid with saturated monohydric alcohols having 1 - 8 carbon atoms, b) 10 - 70% by weight, preferably 35 - 60% by weight, of one or more vinyl aromatic hydrocarbons, c) 0 - 30% by weight, preferably 0 - 15% by weight, of one or more glycidyl esters of alpha-branched aliphatic saturated monocarboxylic acids, d) 25 - 50% by weight of at least one hydroxyalkyl ester or a mixture of at least one alkyl ester and at least one hydroxyalkyl ester of an alpha,beta-olefinically unsaturated monocarboxylic acid, and e) 0 - 10% by weight of one or more alpha,beta-unsaturated monocarboxylic acids,     B) 1 - 6% by weight of ester-soluble nitrocellulose,   C) 0.5 - 1.8% by weight of calcium oxide and D) 25 - 35% by weight of one or more difunctional and polyfunctional polyisocyanates.